These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 36596524

  • 1. IFI6 Downregulation Reverses Oxaliplatin Resistance of Colorectal Cancer Cells by Activating the ROS-Induced p38MAPK Signaling Pathway.
    Huang C, Zhou T, Ma L, Zhao S.
    Biol Pharm Bull; 2023; 46(1):26-34. PubMed ID: 36596524
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism.
    Wang YJ, Xie XL, Liu HQ, Tian H, Jiang XY, Zhang JN, Chen SX, Liu T, Wang SL, Zhou X, Jin XX, Liu SM, Jiang HQ.
    World J Gastroenterol; 2023 Oct 21; 29(39):5452-5470. PubMed ID: 37900995
    [Abstract] [Full Text] [Related]

  • 3. Shikonin potentiates therapeutic efficacy of oxaliplatin through reactive oxygen species-mediated intrinsic apoptosis and endoplasmic reticulum stress in oxaliplatin-resistant colorectal cancer cells.
    Zhang Z, Shen C, Zhou F, Zhang Y.
    Drug Dev Res; 2023 May 21; 84(3):542-555. PubMed ID: 36779379
    [Abstract] [Full Text] [Related]

  • 4. Isolinderalactone sensitizes oxaliplatin-resistance colorectal cancer cells through JNK/p38 MAPK signaling pathways.
    Kwak AW, Park JW, Lee SO, Lee JY, Seo JH, Yoon G, Lee MH, Choi JS, Shim JH.
    Phytomedicine; 2022 Oct 21; 105():154383. PubMed ID: 35987016
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Echinatin induces reactive oxygen species-mediated apoptosis via JNK/p38 MAPK signaling pathway in colorectal cancer cells.
    Kwak AW, Lee JY, Lee SO, Seo JH, Park JW, Choi YH, Cho SS, Yoon G, Lee MH, Shim JH.
    Phytother Res; 2023 Feb 21; 37(2):563-577. PubMed ID: 36184899
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS.
    Cao P, Xia Y, He W, Zhang T, Hong L, Zheng P, Shen X, Liang G, Cui R, Zou P.
    Int J Biol Sci; 2019 Feb 21; 15(8):1676-1684. PubMed ID: 31360110
    [Abstract] [Full Text] [Related]

  • 9. Picropodophyllotoxin Induces G1 Cell Cycle Arrest and Apoptosis in Human Colorectal Cancer Cells via ROS Generation and Activation of p38 MAPK Signaling Pathway.
    Lee SO, Kwak AW, Lee MH, Seo JH, Cho SS, Yoon G, Chae JI, Joo SH, Shim JH.
    J Microbiol Biotechnol; 2021 Dec 28; 31(12):1615-1623. PubMed ID: 34528917
    [Abstract] [Full Text] [Related]

  • 10. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
    Al-Khayal K, Vaali-Mohammed MA, Elwatidy M, Bin Traiki T, Al-Obeed O, Azam M, Khan Z, Abdulla M, Ahmad R.
    BMC Cancer; 2020 Jul 23; 20(1):685. PubMed ID: 32703189
    [Abstract] [Full Text] [Related]

  • 11. Dihydrotanshinone I Inhibits the Proliferation and Growth of Oxaliplatin-Resistant Human HCT116 Colorectal Cancer Cells.
    Wang M, Xiang Y, Wang R, Zhang L, Zhang H, Chen H, Luan X, Chen L.
    Molecules; 2022 Nov 11; 27(22):. PubMed ID: 36431875
    [Abstract] [Full Text] [Related]

  • 12. FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer.
    Chen Y, Deng G, Fu Y, Han Y, Guo C, Yin L, Cai C, Shen H, Wu S, Zeng S.
    Onco Targets Ther; 2020 Nov 11; 13():1625-1635. PubMed ID: 32110058
    [Abstract] [Full Text] [Related]

  • 13. [Synergistic effect of polysaccharide from Trichoderma pseudokoningii and oxaliplatin on colorectal cancer cells in vitro].
    Li P, Yuan P, Que Y, Liu X, Wang G.
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr 20; 41(4):504-513. PubMed ID: 33963708
    [Abstract] [Full Text] [Related]

  • 14. β-Lapachone Exerts Anticancer Effects by Downregulating p53, Lys-Acetylated Proteins, TrkA, p38 MAPK, SOD1, Caspase-2, CD44 and NPM in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells.
    Jung EJ, Kim HJ, Shin SC, Kim GS, Jung JM, Hong SC, Kim CW, Lee WS.
    Int J Mol Sci; 2023 Jun 07; 24(12):. PubMed ID: 37373014
    [Abstract] [Full Text] [Related]

  • 15. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
    Li H, Chen J, Liu J, Lai Y, Huang S, Zheng L, Fan N.
    Exp Cell Res; 2021 Dec 01; 409(1):112892. PubMed ID: 34688609
    [Abstract] [Full Text] [Related]

  • 16. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
    Gao R, Fang C, Xu J, Tan H, Li P, Ma L.
    Arch Biochem Biophys; 2019 Mar 15; 663():183-191. PubMed ID: 30639170
    [Abstract] [Full Text] [Related]

  • 17. Reactive oxygen species-mediated phosphorylation of p38 signaling is critically involved in apoptotic effect of Tanshinone I in colon cancer cells.
    Kim DH, Shin EA, Kim B, Shim BS, Kim SH.
    Phytother Res; 2018 Oct 15; 32(10):1975-1982. PubMed ID: 29876988
    [Abstract] [Full Text] [Related]

  • 18. WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling.
    Cai J, Su L, Luo W.
    Bioengineered; 2022 Jun 15; 13(6):14450-14459. PubMed ID: 35758246
    [Abstract] [Full Text] [Related]

  • 19. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
    Novoa Díaz MB, Carriere P, Gigola G, Zwenger AO, Calvo N, Gentili C.
    World J Gastroenterol; 2022 Jul 14; 28(26):3177-3200. PubMed ID: 36051345
    [Abstract] [Full Text] [Related]

  • 20. Unraveling the immune landscape and therapeutic biomarker PMEPA1 for oxaliplatin resistance in colorectal cancer: A comprehensive approach.
    Zhang Z, Lu T, Zhang Z, Liu Z, Qian R, Qi R, Zhou F, Li M.
    Biochem Pharmacol; 2024 Apr 14; 222():116117. PubMed ID: 38461903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.